Diogo Rau's most recent trade in Lilly(Eli) & Co was a trade of 4,599 Common Stock done at an average price of $1044.7 . Disclosure was reported to the exchange on Feb. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly | Diogo Rau | EVP & CIDO | Grant, award, or other acquisition of securities at price $ 1044.71 per share. | 09 Feb 2026 | 4,599 | 26,396 (0%) | 0% | 1044.7 | 4,804,609 | Common Stock |
| Eli Lilly | Diogo Rau | EVP & CIDO | Grant, award, or other acquisition of securities at price $ 1044.75 per share. | 09 Feb 2026 | 4,432 | 26,229 (0%) | 0% | 1044.7 | 4,630,312 | Common Stock |
| Eli Lilly | Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 3,752 | 0 | - | - | Restricted Stock Unit | |
| Eli Lilly | Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 3,752 | 23,470 (0%) | 0% | 0 | Common Stock | |
| Eli Lilly | Diogo Rau | EVP & CIDO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1037.48 per share. | 01 Feb 2026 | 1,673 | 21,797 (0%) | 0% | 1037.5 | 1,735,710 | Common Stock |
| Eli Lilly | Diogo Rau | EVP & CIDO | Grant, award, or other acquisition of securities at price $ 868.91 per share. | 10 Feb 2025 | 6,815 | 19,718 (0%) | 0% | 868.9 | 5,921,593 | Common Stock |
| Eli Lilly | Diogo Rau | EVP & CIDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 3,752 | 3,752 | - | - | Restricted Stock Unit | |
| Eli Lilly | Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,269 | 0 | - | - | Restricted Stock Unit | |
| Eli Lilly | Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,269 | 14,370 (0%) | 0% | 0 | Common Stock | |
| Eli Lilly | Diogo Rau | EVP & CIDO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 811.24 per share. | 01 Feb 2025 | 1,466 | 12,903 (0%) | 0% | 811.2 | 1,189,282 | Common Stock |
| Eli Lilly | Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 6,300 | 14,146 (0%) | 0% | 0 | Common Stock | |
| Eli Lilly | Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 6,300 | 0 | - | - | Restricted Stock Unit | |
| Eli Lilly | Diogo Rau | EVP & CIDO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 820.34 per share. | 01 Jun 2024 | 3,045 | 11,101 (0%) | 0% | 820.3 | 2,497,935 | Common Stock |
| Eli Lilly | Rau Diogo | EVP & CIDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 3,269 | 3,269 | - | - | Restricted Stock Unit | |
| Eli Lilly | Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 6,300 | 10,694 (0%) | 0% | 0 | Common Stock | |
| Eli Lilly | Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 6,300 | 6,300 | - | - | Restricted Stock Unit | |
| Eli Lilly | Diogo Rau | EVP & CIDO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 429.46 per share. | 01 Jun 2023 | 2,848 | 7,846 (0%) | 0% | 429.5 | 1,223,102 | Common Stock |
| Eli Lilly | Diogo Rau | SVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 7,560 | 7,560 (0%) | 0% | 0 | Common Stock | |
| Eli Lilly | Diogo Rau | SVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 7,560 | 12,600 | - | - | Restricted Stock Unit | |
| Eli Lilly | Diogo Rau | SVP & CIDO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 313.44 per share. | 01 Jun 2022 | 3,166 | 4,394 (0%) | 0% | 313.4 | 992,351 | Common Stock |
| Eli Lilly | Diogo Rau | SVP & CIDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 20,160 | 20,160 | - | - | Restricted Stock Unit |